Evidence map›Paper›PMID 36906612›Full record

ArticleNature communications2023

Clinical NEC prevention practices drive different microbiome profiles and functional responses in the preterm intestine.

Charlotte J Neumann, Alexander Mahnert, Christina Kumpitsch, Raymond Kiu, Matthew J Dalby, Magdalena Kujawska, Tobias Madl, Stefan Kurath-Koller, Berndt Urlesberger, Bernhard Resch and 2 more

Open access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Diagnosing and engineering gut microbiomes.EMBO molecular medicine · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Charlotte J NeumannDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine; Medical University of Graz, Graz, Styria, 8010, Austria.ORCID 0000-0003-0034-4199
Alexander MahnertDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine; Medical University of Graz, Graz, Styria, 8010, Austria.ORCID 0000-0001-7083-8894
Christina KumpitschDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine; Medical University of Graz, Graz, Styria, 8010, Austria.ORCID 0000-0002-2077-2839
Raymond KiuQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.ORCID 0000-0002-4483-1215
Matthew J DalbyQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.ORCID 0000-0002-1137-4337
Magdalena KujawskaChair of Intestinal Microbiome, School of Life Sciences, ZIEL-Institute for Food & Health; Technical University of Munich, Freising, Bavaria, 85354, Germany.ORCID 0000-0002-8842-3512
Tobias MadlGottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Molecular Biology & Biochemistry, Medical University of Graz, Graz, Styria, 8010, Austria.ORCID 0000-0002-9725-5231
Stefan Kurath-KollerDivision of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Styria, 8036, Austria.
Berndt UrlesbergerDivision of Neonatology; Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Styria, 8036, Austria.ORCID 0000-0003-0648-5785
Bernhard ReschDivision of Neonatology; Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Styria, 8036, Austria. bernhard.resch@medunigraz.at.ORCID 0000-0003-4348-8299
Lindsay J HallQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.ORCID 0000-0001-8938-5709
Christine Moissl-EichingerDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine; Medical University of Graz, Graz, Styria, 8010, Austria. christine.moissl-eichinger@medunigraz.at.ORCID 0000-0001-6755-6263
Medical University of Graz · ATNorwich Research Park · GBLeibniz-Institute for Food Systems Biology at the Technical University of Munich · DEUniversity of East Anglia · GB

Funding

Austrian Science Fund FWF DOC 31Austrian Science Fund FWF P 32697Austrian Science Fund FWF W 1226Biotechnology and Biological Sciences Research Council BBS/E/F/00044409Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356Wellcome TrustWellcome Trust 100974/C/13/ZWellcome Trust 220876/Z/20/Z
6 · The paper itself

Abstract

Preterm infants with very low birthweight are at serious risk for necrotizing enterocolitis. To functionally analyse the principles of three successful preventive NEC regimens, we characterize fecal samples of 55 infants (<1500 g, n = 383, female = 22) longitudinally (two weeks) with respect to gut microbiome profiles (bacteria, archaea, fungi, viruses; targeted 16S rRNA gene sequencing and shotgun metagenomics), microbial function, virulence factors, antibiotic resistances and metabolic profiles, including human milk oligosaccharides (HMOs) and short-chain fatty acids (German Registry of Clinical Trials, No.: DRKS00009290). Regimens including probiotic Bifidobacterium longum subsp. infantis NCDO 2203 supplementation affect microbiome development globally, pointing toward the genomic potential to convert HMOs. Engraftment of NCDO 2203 is associated with a substantial reduction of microbiome-associated antibiotic resistance as compared to regimens using probiotic Lactobacillus rhamnosus LCR 35 or no supplementation. Crucially, the beneficial effects of Bifidobacterium longum subsp. infantis NCDO 2203 supplementation depends on simultaneous feeding with HMOs. We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.

Indexed as

Gastrointestinal MicrobiomeInfant, PrematureBifidobacterium longum subspecies infantisEcosystemFecesFemaleHumansInfantInfant, NewbornIntestinesRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID36906612
PMCPMC10008552
OpenAlexW4323923876

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read55
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.